EXCELLA Post-Approval Study

计划入组 57 人 · 首次发布于 2013 年 12 月 12 日

Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"

计划入组 360 人 · 首次发布于 2008 年 11 月 18 日

NXC-401

Mesenchymal stem cell therapy (NextCell Pharma)

p47/gp91 gene therapy(Nexell Therapeutics, Inc.)

Excella GmbH

Germany

Excella GmbH & Co. KG

Germany

Axcella Health

United States

Nexcella's NXC-201 Shows Promise in Multiple Myeloma and AL Amyloidosis

Nexcella Completes Pre-IND Meeting with FDA for NXC-201 in Multiple Myeloma and AL Amyloidosis

Immix Biopharma's Nexcella to Initiate US Dosing of NXC-201 CAR-T Therapy for AL Amyloidosis